Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38936 |
KRAS G13D peptide, 25 mer
KRAS G13D peptide, 25 mer |
||
KRAS G13D peptide, a 25-mer sequence, is derived from the KRAS activating oncogene mutation and serves as an immune potentiator. This peptide possesses immunogenic properties and can be utilized for the development of a KRAS vaccine. |